U.S. markets closed
  • S&P Futures

    3,281.75
    +18.25 (+0.56%)
     
  • Dow Futures

    26,564.00
    +155.00 (+0.59%)
     
  • Nasdaq Futures

    11,188.50
    +55.75 (+0.50%)
     
  • Russell 2000 Futures

    1,545.90
    +6.70 (+0.44%)
     
  • Crude Oil

    37.64
    +0.25 (+0.67%)
     
  • Gold

    1,879.90
    +0.70 (+0.04%)
     
  • Silver

    23.49
    +0.13 (+0.56%)
     
  • EUR/USD

    1.1754
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • Vix

    40.28
    +6.93 (+20.78%)
     
  • GBP/USD

    1.2990
    +0.0003 (+0.02%)
     
  • USD/JPY

    104.3330
    +0.0320 (+0.03%)
     
  • BTC-USD

    13,257.03
    -0.65 (-0.00%)
     
  • CMC Crypto 200

    261.91
    -10.78 (-3.95%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,418.51
    -67.29 (-0.29%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AYX, QTT and NNOX

·3 mins read

NEW YORK, NY / ACCESSWIRE / October 4, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Alteryx, Inc. (NYSE:AYX)
Class Period: May 6, 2020 - August 6, 2020
Lead Plaintiff Deadline: October 19, 2020

During the class period, Alteryx, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was unable to close large deals within the quarter, and deals were pushed out to subsequent quarters or downsized; (2) as a result, Alteryx increasingly relied on adoption licenses to attract new customers; (3) as a result and due to the nature of adoption licenses, the Company's revenue was reasonably likely to decline; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in AYX: http://www.kleinstocklaw.com/pslra-1/alteryx-inc-loss-submission-form?id=9786&from=1

Qutoutiao Inc. (NASDAQ:QTT)
This lawsuit is on behalf of persons and entities that: a) purchased or otherwise acquired Qutoutiao American Depositary Shares pursuant and/ortraceable to the registration statement and prospectus issued in connection with the Company's September 2018 initial public offering; and/or b) purchased or otherwise acquired Qutoutiao securities between September 14, 2018 and July 15, 2020.
Lead Plaintiff Deadline: October 19, 2020

The QTT lawsuit alleges that Qutoutiao Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Qutoutiao replaced its advertising agent with a related party, thereby bypassing third-party oversight of the content and quality of the advertisements; (2) the Company placed advertisements on its mobile app for products whose claims could not be substantiated and thus were considered false advertisements under applicable regulations; (3) as a result, the Company would face increasing regulatory scrutiny and reputational harm; (4) as a result, the Company's advertising revenue was reasonably likely to decline; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in QTT: http://www.kleinstocklaw.com/pslra-1/qutoutiao-inc-loss-submission-form-2?id=9786&from=1

Nano-X Imaging Ltd. (NASDAQ:NNOX)
Class Period: August 21, 2020 - September 15, 2020
Lead Plaintiff Deadline: November 16, 2020

The complaint alleges Nano-X Imaging Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) Nano-X's commercial agreements and its customers were fabricated; (2) Nano-X's statements regarding its "novel" Nanox System were misleading as the Company never provided data comparing its images with images from competitors' machines; (3) Nano-X's submission to the U.S. Food and Drug Administration admitted the Nanox System was not original; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in NNOX: http://www.kleinstocklaw.com/pslra-1/nano-x-imaging-ltd-loss-submission-form?id=9786&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/609037/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-AYX-QTT-and-NNOX